List of insiders holdings for MADRIGAL PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | CxSynta LLC CAXTON CORP 10% Owner | 2015-11-20 19:00:14 | 28,991,306 0 | 28,991,306 | Form 13D |
| 2 | Kovner Bruce Director 10% Owner | 2015-12-08 14:09:10 | 3,092,677 18,019,580 | 21,112,257 | Form 4 |
| 3 | Chen Lin Huey 10% Owner | 2010-02-12 18:21:53 | 0 2,570,947 | 2,570,947 | Form 5/A |
| 4 | Bahcall Safi R President and CEO | 2014-02-13 16:25:26 | 1,853,135 580,000 | 2,433,135 | Form 5 |
| 5 | Chen Lan Bo Director | 2013-02-14 06:03:03 | 2,387,284 0 | 2,387,284 | Form 13G |
| 6 | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 667 L.P. Baker Brothers Life Sciences LP Director | 2025-08-20 18:12:22 | 0 1,947,968 | 1,947,968 | Form 4 |
| 7 | Taub Rebecca Director | 2025-08-13 17:33:26 | 504,307 655,540 | 1,159,847 | Form 4 |
| 8 | FRIEDMAN PAUL A Director | 2025-08-13 18:18:57 | 187,164 655,540 | 842,704 | Form 4 |
| 9 | WILSON ROBERT N Director | 2015-07-06 16:38:33 | 780,936 0 | 780,936 | Form 4 |
| 10 | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 2023-12-13 16:05:57 | 567,644 0 | 567,644 | Form 13D |
| 11 | CRAVES FRED B Director | 2025-03-14 16:25:06 | 357,818 33,471 | 391,289 | Form 4 |
| 12 | Ramachandra Sumant President, R&D | 2013-03-13 17:53:37 | 300,000 0 | 300,000 | Form 4 |
| 13 | Bernitz Steven B SVP, Corporate Development | 2013-12-20 16:23:42 | 175,000 0 | 175,000 | Form 4 |
| 14 | Vukovic Vojo SVP, Chief Medical Officer | 2015-10-06 17:33:43 | 132,300 0 | 132,300 | Form 4 |
| 15 | McMahon Arthur SVP, Human Resources | 2015-03-04 17:15:49 | 126,768 0 | 126,768 | Form 4 |
| 16 | Sibold William John President and CEO | 2025-08-21 17:44:27 | 109,753 0 | 109,753 | Form 4 |
| 17 | Whitaker Anne Clem President and CEO | 2015-03-04 17:00:57 | 100,000 0 | 100,000 | Form 4 |
| 18 | Chadwick Jeremy G Sr. VP, Pgm Mgmt and Clin Ops | 2010-03-03 16:50:15 | 97,186 0 | 97,186 | Form 4 |
| 19 | REARDON WILLIAM S Director | 2015-07-06 16:34:50 | 69,392 0 | 69,392 | Form 4 |
| 20 | Ehrlich Keith S VP, Fin. and Admin., CFO | 2014-03-05 19:03:06 | 66,985 0 | 66,985 | Form 4 |
| 21 | Koya Keizo Sr. VP, Drug Development | 2012-03-08 20:20:33 | 63,036 0 | 63,036 | Form 4 |
| 22 | Jacobson Eric W Sr. VP, Research and CMO | 2009-04-14 16:51:45 | 47,112 0 | 47,112 | Form 4 |
| 23 | Barsoum James G Sr. VP, Research | 2009-04-14 16:46:10 | 42,900 0 | 42,900 | Form 4 |
| 24 | Williams Martin D Sr. VP, Business Dev., CBO | 2008-02-29 14:00:34 | 42,120 0 | 42,120 | Form 4 |
| 25 | Schor Chen Former President and CEO | 2016-07-22 17:23:27 | 37,178 0 | 37,178 | Form 4 |
| 26 | Schneebaum Marc R Chief Financial Officer | 2021-02-23 13:32:44 | 32,000 0 | 32,000 | Form 4 |
| 27 | Howarth Alex G. Chief Financial Officer | 2024-01-25 15:29:59 | 30,778 0 | 30,778 | Form 4 |
| 28 | BAILEY MICHAEL P Sr. VP, Chief Comm. Officer | 2010-08-06 16:41:58 | 29,627 0 | 29,627 | Form 4 |
| 29 | Lynch Brian Joseph SVP and General Counsel | 2024-01-25 15:24:30 | 26,813 530 | 27,343 | Form 4 |
| 30 | Levy Richard S Director | 2025-06-24 16:42:30 | 22,487 0 | 22,487 | Form 4 |
| 31 | Soergel David Chief Medical Officer | 2025-05-16 18:23:51 | 20,384 0 | 20,384 | Form 4 |
| 32 | KUFE DONALD W Director | 2015-07-06 16:32:21 | 20,000 0 | 20,000 | Form 4 |
| 33 | Morenstein Scott D Director | 2016-01-05 18:32:11 | 17,857 0 | 17,857 | Form 4 |
| 34 | Rieder Wendy E Former SVP, Gen. Counsel | 2016-07-22 17:18:07 | 17,730 0 | 17,730 | Form 4 |
| 35 | Huntsman Carole Chief Commercial Officer | 2025-03-07 16:31:44 | 17,693 0 | 17,693 | Form 4 |
| 36 | Singh Amar Sr. VP, Chief Business Officer | 2014-02-13 16:23:05 | 15,161 0 | 15,161 | Form 5 |
| 37 | Sukhija Remy Chief Commercial Officer | 2023-01-18 20:00:34 | 15,001 0 | 15,001 | Form 4 |
| 38 | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2025-03-07 17:40:05 | 14,383 0 | 14,383 | Form 4 |
| 39 | Dier Mardi SVP and CFO | 2025-03-12 16:32:09 | 10,440 0 | 10,440 | Form 4 |
| 40 | MILLIGAN DAVID V Director | 2022-06-21 06:30:25 | 9,470 0 | 9,470 | Form 4 |
| 41 | Gollust Keith R Director | 2022-06-21 06:30:09 | 9,470 0 | 9,470 | Form 4 |
| 42 | Kelley Shannon T General Counsel | 2025-08-18 17:33:51 | 9,173 0 | 9,173 | Form 4 |
| 43 | Folkman Judah Director | 2007-07-03 08:47:10 | 7,676 0 | 7,676 | Form 4 |
| 44 | Daly James M Director | 2025-06-24 16:34:25 | 3,917 0 | 3,917 | Form 4 |
| 45 | Brennan Daniel J. Director | 2025-08-05 19:23:22 | 2,672 0 | 2,672 | Form 4 |
| 46 | BATE KENNETH Director | 2025-08-15 18:04:57 | 2,627 0 | 2,627 | Form 4 |
| 47 | FOUSE JACQUALYN A Director | 2025-06-24 16:39:48 | 1,463 0 | 1,463 | Form 4 |
| 48 | Cheong Raymond Director | 2023-06-20 06:19:37 | 0 0 | 0 | Form 3 |